All posts by medical

Ouachita professor Nathan Reyna invited to National Science Foundation-funded mentor program – Ouachita Baptist University News

Dr. Nathan Reyna

Dr. Nathan Reyna, Ouachita Baptist Universitys associate professor of biology, has been selected to participate in the National Science Foundations (NSF) mentor program, CURE Net.

Dr. Reyna will have the opportunity to serve as a mentor to other science professors in the country and teach them how to run course-embedded undergraduate research experiences (CUREs) in their own institutions. This program mirrors several programs Ouachitas J.D. Patterson School of Natural Sciences already sponsors, which is among the reasons Dr. Reyna was invited to participate.

Currently, Ouachita has five CURE programs embedded into its curriculum, coordinated primarily by Dr. Reyna and Dr. Ruth Plymale, associate professor of biology. One of these CUREs focuses on synthetic biology, where students select three different genes from different organisms and put them together. Reyna and Plymale received funding through the NSF-funded EPSCoR program to create the Arkansas CURE (AR:CURE) project to helpf faculty at other institutions develop similar programs. Over the summer, 18 undergraduate faculty from 10 states participated in a three-day workshop focused on this CURE. Dr. Reyna taught these professors how to execute the experiment in a classroom setting. This workshop was so successful, Reyna noted, that funding was secured to conduct the workshop for three more years.

We teach them how to assess student learning, how to do all the different things over the course of the semester with groups that are never in the same spot at any given time, Dr. Reyna explained. Thats what we do in the workshop, and thats what we do here at Ouachita. Several years ago, the biology department changed how we taught science. It is amazing that these ideas have now expanded to us helping other schools and universities.

Ouachita recently received funding to start another mentorship program with high school students and faculty. This program will take place next semester and will allow high school students and faculty to learn Ouachitas Bioinformatics CURE. This CURE allows students to use computers to analyze the genetic sequence of a bacteriophage. Ouachita students will now have the opportunity to teach and mentor people from surrounding high schools about this CURE. After the workshop, the high school faculty will have access to the program so they can share it with their students.

Were going to call it a Genome Hackathon, Dr. Reyna said. Were going to hack a virus during the course of a day. Were trying to get our students to serve as mentors, and were getting role models into the community. Were trying to increase interest in science, technology, engineering and math in the area.

In addition to these two CUREs, Ouachita has three others, focusing on a phage lab, genetics and cell biology. Ouachita has five CUREs in total in its curriculum, whereas many schools have only one, according to Reyna. The hands-on learning opportunities are an important part of the high-impact educational process for Ouachita science students.

Students will use this in the future, especially learning how to read a protocol, Dr. Reyna said. A lot of times it wont be the same protocol, but it will be the same thing when someone says, Here, read this, Ill help you for a day, but then youre on your own to redo it and think about how to fix it. Those skills are used forever. We are teaching students to learn and think like a scientist from day one.

Dr. Reyna will be able to use similar methods in place now in Ouachitas Patterson School for the NSFs CURE Net program. For more information on the CURE Net program or Ouachitas CUREs, contact Dr. Nathan Reyna at reynan@obu.edu or (870) 245-5240.

By Katie Smith

September 1, 2017

View post:
Ouachita professor Nathan Reyna invited to National Science Foundation-funded mentor program - Ouachita Baptist University News

Scientists discover potential new improved way to kill cancer cells – Medical Xpress

Scientists at the University of Glasgow have discovered a process to trigger the death of cancer cells that could be more effective than current methods.

The new method of killing cancer cells called Caspase Independent Cell Death (CICD), and published today in Nature Cell Biology, led to the complete eradication of tumours in experimental models.

Currently most anti-cancer therapies (chemotherapy, radiation and immunotherapy) work by killing cancer cells through a process called apoptosis, which activates proteins called caspases, leading to cell death.

But in apoptosis, therapies often fail to kill all cancer cells, leading to disease recurrence, and can also have unwanted side effects that may even promote cancer.

The scientists wanted to develop a way to improve therapy that induces cancer cell killing while also mitigating unwanted toxicity.

Dr Stephen Tait, Cancer Research UK Beatson Institute, Institute of Cancer Sciences, said: "Our research found that triggering Caspase-Independent Cell Death (CICD), but not apoptosis, often led to complete tumour regression.

"Especially under conditions of partial therapeutic response, as our experiments mimic, our data suggests that triggering tumour-specific CICD, rather than apoptosis, may be a more effective way to treat cancer."

Unlike apoptosis, which is a silent form of cell death, when cancer cells die through CICD, they alert the immune system through the release of inflammatory proteins.

The immune system can then attack the remaining tumour cells that evaded initial therapy-induced death.

The researchers used lab-grown colorectal cancer cells to show the advantage of killing cancer cells via CICD, however, these benefits may be applicable to a wide-range of cancer types.

He added: "In essence, this mechanism has the potential to dramatically improve the effectiveness of anticancer therapy and reduce unwanted toxicity. Taking into consideration our findings, we propose that engaging CICD as a means of anti-cancer therapy warrants further investigation."

Dr Justine Alford, Cancer Research UK's senior science information officer, said: "Although many cancer treatments work by triggering apoptosis, that method sometimes fails to finish the job and instead may lead to the tumour becoming harder to treat.

"This new research suggests there could be a better way to kill cancer cells which, as an added bonus, also activates the immune system. Now scientists need to investigate this idea further and, if further studies confirm it is effective, develop ways to trigger this particular route of cell death in humans."

The paper, 'Mitochondrial permeabilization engages NF-kB-dependent anti-tumour activity under caspase deficiency,' is published in Nature Cell Biology.

Explore further: Protein that promotes 'cell-suicide' could revolutionise eye cancer treatment

More information: Evangelos Giampazolias et al. Mitochondrial permeabilization engages NF-B-dependent anti-tumour activity under caspase deficiency, Nature Cell Biology (2017). DOI: 10.1038/ncb3596

Read more:
Scientists discover potential new improved way to kill cancer cells - Medical Xpress

Biochemist Studies How Viruses Replicate, Cause Infection – CSUF News

Biochemist Marcos E. Ortega, a native of El Paso, Texas, studied how viruses replicate at the University of Colorado Denver and Health Sciences Center, where he earned a doctorate in biochemistry. Following postdoctoral fellowships at USC and Harvey Mudd College, he landed a teaching position in 2013 at Macalester College in St. Paul, Minnesota.

This fall semester, he joins Cal State Fullerton as an assistant professor of chemistry and biochemistry. Ortega also holds a bachelor's degree in chemistry from Grinnell College in Iowa.

"I chose to pursue a career in academia as I truly love the combination of teaching and research," said Ortega, who also speaks Spanish. "I wanted to pursue a path that allowed me to impact the community and students in a very personal way through teaching, mentoring, outreach and service work."

I was inspired to pursue biochemistry and education by two things: the passing of my grandfather from diabetes when I was a teen and the teaching career of my mother. When I chose to pursue chemistry in college, it was biochemistry and the molecular origins of disease that piqued my interest the most. I sought answers in biochemistry about diabetes, which helped me to deal with the loss of my grandfather. It was truly a case where knowledge was power, and I utilize these lessons to this day in my classes. I was also inspired by the patience and significant impact that my mom had on students as a first-grade teacher. I want to have that same type of impact on others and a career in academics married my desire to impact students with the molecular understanding and prevention of disease and infection.

My research interests lie in trying to understand viral infection and viral replication using biochemical techniques and studies. I seek to understand how biophysical and biochemical principles guide the spontaneous assembly of a mature virus in a host cell. At the core, I want to investigate how viruses replicate and assemble and thus cause infection by studying the relation between protein structure and function.

I hope students learn that biochemistry is important to all people and impacts our lives on a daily basis. I want students to find a personal connection to biochemistry that hopefully motivates them to learn more. I also want students to find their place in the world and realize the importance of education. I know all students will not pursue biochemistry or biophysics, but through my teaching, I want students to know that anything is possible with a strong work ethic and an education.

I would like people to know that the answers to many of the difficult questions in todays world may be right in front of us. Whether its treatments for cancer, feeding the hungry, environmental issues or sustainable energy, the foundations of cellular function and the chemistry that drives it may begin to illuminate some answers that will help us prosper and advance as a society.

See more here:
Biochemist Studies How Viruses Replicate, Cause Infection - CSUF News

Tomatoes’ ‘Crystal Ball’ Reveals Evolutionary Secrets – Laboratory Equipment

Michigan State Universitys Robert Last studies tomatoes. Specifically, he researches their hair, or trichomes.

For this study, he focused on a single type of molecule in trichomes acylsugars. The secrets Last and a team of MSU scientists found from studying these specialized metabolites open an evolutionary window for the emerging field of plant defense metabolism, insights that could lead to engineering advances for better pest resistance and human medicine.

There are an estimated 300,000 species of plants in the world, producing roughly more than a million metabolites. Plants use these molecules to grow, communicate with each other or to defend themselves against pests and disease. Humans benefit from many of these products for food, medicines and industrial uses. Thousands of core metabolites are found in every plant, but hundreds of thousands are more specialized and found only in specific groups of plants.

Acylsugars are an example of a group of specialized metabolites found only in the Solanaceae family, which includes tomato and petunia plants. These specialized metabolites have a wide variety of structures and are made by different enzymes working together to carry out a series of biochemical reactions.

We sought to understand how this novel pathway originated and diversified across 100 million years of plant evolution, said Last, MSU Barnett Rosenberg Professor of Biochemistry and Molecular Biology and Plant Biology and the studys senior author. This is our crystal ball, our view into evolution.

The crystal ball revealed that many of the enzymes that make acylsugars are promiscuous, meaning that they could use a variety of molecules as starting points for their chemical reactions. This could be the key as to how the plants make a variety of acylsugars.

The scientists also discovered that many of the enzymes that make acylsugars are encoded by genes that were originally copies of other genes and that have subsequently evolved new roles.

Deciphering these codes are important because tomatoes acylsugars are natural pesticides. Engineering plants to produce acylsugars could reduce pesticide use in crop production. Additionally, some of these mechanisms could help make chemicals that have pharmaceutical value, including ones that treat cancer and heart conditions.

Plants are master chemists, and were only just beginning to understand the metabolic pathways that they use to produce these amazing compounds, said Last, whos also an MSU AgBioResearch scientist. By understanding how the pathways evolved to produce these enzymes could lead to innovative ways to make valuable compounds on a large scale.

The MSU team of scientists contributing to this research included Gaurav Moghe, Bryan Leong, Steven Hurney and Daniel Jones. The paper is published in the current issue of the journal eLife.

See more here:
Tomatoes' 'Crystal Ball' Reveals Evolutionary Secrets - Laboratory Equipment

Lopez named Vanderbilt’s liaison to Oak Ridge National Laboratory – Vanderbilt University News

by Erin Facer | Wednesday, Aug. 30, 2017, 11:54 AM

Carlos Lopez (Vanderbilt University)

Carlos F. Lopez, assistant professor of biochemistry and biomedical informatics, has been appointed as Vanderbilt Universitys liaison to Oak Ridge National Laboratory, the U.S. Department of Energys largest science and energy laboratory conducting research in energy and security. Lopez will continue the many collaborations that Greg Walker, associate professor of mechanical engineering, initiated during his term in this role.

Carlos expertise at the interface of physical, biological and computer sciences is precisely what is needed to help Vanderbilt University develop closer scientific collaborations with Oak Ridge National Lab, Vice Provost for Research Padma Raghavan said. I am grateful to him for stepping into this role, and I look forward to working with him to further develop this important partnership.

Carlos is an energetic and interactive investigator who already has productive collaborations with Oak Ridge scientists. He is very well suited for this new role, added Larry Marnett, dean of basic sciences at the School of Medicine.

As the Vanderbilt liaison to ORNL, Lopez will work closely with Vanderbilt faculty, the Office of the Provost, university deans and Vanderbilt University Medical Center leadership to advance key research themes that align with both Vanderbilt and ORNL priorities.

I would like to be instrumental in bringing together researchers from both institutions to develop robust collaborations to accelerate discovery, Lopez said.

Lopez received his Ph.D. in physical chemistry from the University of Pennsylvania. He pursued a postdoctoral fellowship at the University of Texas at Austin, where he studied theoretical biophysics, and followed this with a postdoctoral position at Harvard Medical School. He moved to Vanderbilt University School of Medicine in late 2012 as an assistant professor of cancer biology. His work develops and applies novel computational modeling tools and leverages strong experimental collaborations to describe intracellular biochemical signaling networks to further our understanding of cellular decision-making processes.

Media Inquiries: Erin Facer, erin.facer@vanderbilt.edu

Read the original:
Lopez named Vanderbilt's liaison to Oak Ridge National Laboratory - Vanderbilt University News

Grey’s Anatomy: We Need to Talk About Jaggie – TV Guide

Now PlayingGrey's Anatomy 7 Worst Couples/Hookups, Ranked

Ever since Season 1 of Grey's Anatomy, fans have joked about the "incestuous" relationships among the show's doctors. Despite being close enough to their colleagues to consider them family, the doctors and residents at Grey Sloan (nee Seattle Grace) often found themselves falling into bed together. Like, really often.

But as the show prepares to enter its 14th season, the term "incest" may no longer be such a misnomer -- and some fans aren't having it.

We're talking, of course, about the budding romance between step-siblings Maggie Pierce (Kelly McCreary) and Jackson Avery (Jesse Williams), a pairing that seemed to emerge out of nowhere when none other than Jackson's ex-wife April (Sarah Drew) told Maggie it was clear Jackson had feelings for her in the Season 13 finale.

(via giphy)

Well, OK, maybe the spark didn't come out of nowhere. Maggie did turn to Jackson for support after her mother died in Season 13 -- even though he had kept Mrs. Pierce's condition a secret from Maggie while he was treating her. After that, they certainly seemed to grow closer at the hospital. But April's observation still came a little out of left field.

Grey's Anatomy Mega Buzz: Are Maggie and Jackson Actually a Thing?

After her failed romance with DeLuca (Giacomo Gianniotti) and unrequited crush on Riggs (Martin Henderson), it sounds like Maggie is just eenie-meenie-miney-mo'ing her way around the men at her workplace, without much success. Would it kill her (or any of the other doctors, for that matter) to maybe try an online dating service for once?

And a Maggie-Jackson romance provides yet another very convenient roadblock to keep Jackson and April -- a popular couple shipped by many fans who share a child, have their own hashtag (#Japril) and had an entire episode devoted to themselves last season -- apart for at least the better part of another year.

Also, and I believe I mentioned this earlier: the two are step-siblings. Maggie's father Richard (James Pickens Jr.) is married to Jackson's mother Catherine (Debbie Allen). What is this, Game of Thrones?

Whether Maggie and Jackson will actually take the plunge remains to be seen, but fans seem to be pretty divided about the potential pairing.

This week, Williams himself noted that fans seem to be "evenly divided" over the issue, but seemed to maybe indicate that he's not on board with it, retweeting a fan-made anti-Jaggie meme with the simple observation, "Very good."

Look, don't get me wrong: ever since Maggie's character was introduced at the end of Season 10, she's been one of the more interesting and likable characters on the show -- but has suffered nothing but heartache. The closest we've seen her come to having a relationship was her short-lived dalliances with DeLuca and her mostly offscreen stint with the radiologist Ethan. It would be great to see Maggie in a long-term, fulfilling relationship, the likes of which we've seen almost all of the other Grey's characters involved in. Not only is it about time for Maggie to have something good happen to her, giving her a significant other would also provide a wealth of potential drama for a character who longs for a partner -- despite having made her studies and career a priority for her whole life (and who we know has deemed herself incapable of sleeping next to other people).

But a Maggie-Jackson pairing seems like merely a plot device, an arbitrary pairing-off that makes Maggie little more than a pawn in the larger #Japril storyline. There's no denying that there is chemistry between Williams and McCreary; but up until this point it's seemed to be more of the brother/sister variety because, well, that's what they are. Plus, with so many fans already voicing their disdain for the romance before it's even officially happened, it will be a difficult task for the writers and actors to develop the two characters into a couple worth rooting for. And the alternative -- turning viewers against one or both of the mostly beloved characters -- is almost worse. It would be a better idea to put the idea of Jaggie to bed rather than in one.

Also, ew.

Grey's Anatomy kicks off Season 14 with a two-hour premiere Thursday, Sept. 28 at 8/7c on ABC.

See the article here:
Grey's Anatomy: We Need to Talk About Jaggie - TV Guide

Anatomy & Cell Biology | IU School of Medicine

As one of the founding basic science departments at IU School of Medicine, the Department of Anatomy and Cell Biology has a long-standing and diverse history of anatomical science education and research dating back a hundred years. Today, modern anatomy as a scientific discipline encompasses cell and molecular biology, neuroscience, developmental biology, evolution, vertebrate paleontology, and anthropology, and this area of medicine leads the way in imaging technology and imaging-based research.

Continue reading here:
Anatomy & Cell Biology | IU School of Medicine

The Anatomy of an Upset: How South can beat Ole Miss – WKRG

MOBILE, Ala. As far as this Saturday, we know Ole Miss is a very good opponent, said South Alabama coach Joey Jones. Were ready to go to a SEC school, and a SEC stadium to play a ballgame. Its exciting for our players.

The anatomy of an upset. It all starts with a mindset. A belief anything is possible.

Theyre not intimidated by the venue. Weve been to Tennessee, weve been to South Carolina and Mississippi State, said Jones. I think they have a little chip on their shoulder. They want to show people what they can do.

To pull off an upset, you have to be prepared. The Jags have been in fall camp for nearly a month.

They know toughness is going to win. They know toughness is going to win on the road. Toughness is going to win those close ballgames, said Jones.

And they have more depth than ever.

A crucial component if you want to beat a SEC foe.

If you look at it over the years, most of those games we sort of wore down at the end of the game. They would kind of get us late in the fourth quarter because were just tired. So having those fresh legs in their will certainly make a difference, said Jones.

Depth, preparation and a belief in yourself and your unit, the necessary ingredients to pull off an upset.

Now its time to put it all to the test.

Were going to bring this program to the next level. Thats our goal this year, said Jones.

Read the original here:
The Anatomy of an Upset: How South can beat Ole Miss - WKRG

Grey’s Anatomy: Jo Is Desperate for Family Without Stephanie Around – TV Guide

Now PlayingGrey's Anatomy: How Will Jo Manage Without Stephanie?

Poor Jo!

That's not a statement we use much in relation to Grey's Anatomy, but we have to admit that homegirl has had it rough the past couple of seasons. On top of losing her fiance, drama causing her to fall behind in the residents program and her coworker falling in love with her, Jo's (Camilla Luddington) best friend is now leaving Grey Sloan to find herself.

That leaves one lonely Jo running around the hospital, and that's pretty damn sad. Stephanie (Jerrika Hinton) was like a sister to Jo, Luddington told TV Guide at the Television Critics Association summer press tour. However, with Stephanie gone Jo will be looking for someone else to lean on.

Grey's Anatomy: Catherine Almost Sidelined Bailey Over Karev's Assault

"I think Jo is going to try and attempt to lean on Ben a bit this season," Luddington confessed. "Is it successful? I don't know. I think she's trying to pull anyone close to her and that's another resident...As for other women, I don't know yet. That'll be interesting."

See if Jo gets a new BFF when Grey's Anatomy returns for a two-hour premiere on Thursday, Sept. 28 at 8/7c on ABC.

Read the rest here:
Grey's Anatomy: Jo Is Desperate for Family Without Stephanie Around - TV Guide

Grabit’s Robots Produce Nike Shoes 20 Times Faster Than Humans Do – The Merkle

It is no secret most robots will be far better at making products and goods thantheir human counterparts ever will be. According to Grabit, the companysline of robots is capable of working at 20 times the pace of anaverage human. These robots are designed to build pairs of Nike shoes. Flooding the market with the finished product may help to push the shoesaverage price down by quite a bit. It is one of those developments people will both love and hate at the same time.

Very few people consider how much work goes into the process of putting a pair of shoes together. The amount of labor required for this specific purpose should not be overlooked. The upper part of the shoe which sits on top of your foot is actually the most laborious task ofall to complete. It is not comprised of one single piece of material. Humans often have to put together a few dozen individual pieces in order to create this part of the shoe. Up until now, no robot hadbeen able to produceadequate results whenputting this part together.

Grabit claims that has now changed. The company has built a robot which is capable of fully assembling pairs of Nike shoesquickly. Considering how Nike, Inc. invested millions in this company, it is about time those efforts pay off. It is worth noting how the robots rely on static electricity known as electroadhesion to help manipulate objects in unique ways. This allows the robots to assemble every single part of a shoe with relative ease. It does so at 20 times the pace of a human worker, which is both amazing and terrifying.

So far, a few Nike facilities have been equipped with Grabit robots to fully test their performance over time. It is expected around 12 of these machines will be operating across both Mexico and China before December 31st of this year. Thiswould certainly allow Nike to shake up itsmanufacturing process quite a bit and bring it closer to itsmajor consumer market. If this trial were successful, it could mean positive things for the industrys negative association with child labor as well.

Automation is coming to the manufacturing sector. So far, no major companies have deployed such technology on any sizeable scale, though. Robotic arms have been the main area of focus for the time being, although other technologies are being considered as well. Entrusting robots with more meticulous work is a big gamble by Nike, but so far, the companysefforts are paying off. Only time will tell whether or not their gut feeling was the right one, though.

Grabits robots do not mimic human behavior. They use flat pads of electrodes which create an electrical field adhering to virtually any surface one can think of. This is very different from most robotic hand-oriented projects in the industry right now. It is more likehow one would expect robots to behave, rather than an imitation of human workforce. It does not appear the company faces any major competition right now, which makes them rather unique for the time being.

Moreover, Grabits robots can work together with human operators, which is another big selling point. The software decides how the various pieces shouldbe stacked, and lights up positions for the human partner to set things down. The system currently requiresone human employee to monitor one machine per shift, which should improve overall productivity by up to 2,000%. This is a very interesting development that shows that not all robots are designed to take human jobs.

See more here:
Grabit's Robots Produce Nike Shoes 20 Times Faster Than Humans Do - The Merkle